These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35513529)

  • 1. A national precision cancer medicine implementation initiative for Norway.
    Taskén K; Russnes HEG; Aas E; Bjørge L; Blix ES; ; Enerly E; Fagereng GL; Flobak Å; Gilje B; Gjertsen BT; Guren TK; Heix J; Hovig E; Hovland R; ; ; Lønning PE; Meza-Zepeda LA; Mæhle PM; Nilsen HL; Thoresen SØ; Widerberg K; Smeland S; Helland Å
    Nat Med; 2022 May; 28(5):885-887. PubMed ID: 35513529
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
    Helland Å; Russnes HG; Fagereng GL; Al-Shibli K; Andersson Y; Berg T; Bjørge L; Blix E; Bjerkehagen B; Brabrand S; Cameron MG; Dalhaug A; Dietzel D; Dønnem T; Enerly E; Flobak Å; Fluge S; Gilje B; Gjertsen BT; Grønberg BH; Grønås K; Guren T; Hamre H; Haug Å; Heinrich D; Hjortland GO; Hovig E; Hovland R; Iversen AC; Janssen E; Kyte JA; von der Lippe Gythfeldt H; Lothe R; Lund JÅ; Meza-Zepeda L; Munthe-Kaas MC; Nguyen OTD; Niehusmann P; Nilsen H; Puco K; Ree AH; Riste TB; Semb K; Steinskog ESS; Stensvold A; Suhrke P; Tennøe Ø; Tjønnfjord GE; Vassbotn LJ; Aas E; Aasebø K; Tasken K; Smeland S
    J Transl Med; 2022 May; 20(1):225. PubMed ID: 35568909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national precision cancer medicine implementation initiative for Finland.
    Jalkanen KJ; Alanne E; Iivanainen S; Kääriäinen OS; Tanner M; Auranen A; Koivunen J; Nykopp TK; Vihinen P; Mustonen M
    Acta Oncol; 2024 May; 63():395-397. PubMed ID: 38779937
    [No Abstract]   [Full Text] [Related]  

  • 4. Precision Medicine: Accelerating the Science to Revolutionize Cancer Care
.
    Brant JM; Mayer DK
    Clin J Oncol Nurs; 2017 Dec; 21(6):722-729. PubMed ID: 29149123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in the era of precision cancer medicine - for the few or for the many?
    Russnes HG
    Acta Oncol; 2020 Jul; 59(7):731-732. PubMed ID: 32579040
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Strategic' development of precision cancer medicine in the United States.
    Schilsky RL
    Mol Oncol; 2021 Jul; 15(7):1747-1749. PubMed ID: 34053185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine initiative boosts funding for NCI efforts: Proposal would help broaden availability of targeted therapies.
    Printz C
    Cancer; 2015 Oct; 121(19):3369-70. PubMed ID: 26383789
    [No Abstract]   [Full Text] [Related]  

  • 8. Opportunities for the Cardiovascular Community in the Precision Medicine Initiative.
    Shah SH; Arnett D; Houser SR; Ginsburg GS; MacRae C; Mital S; Loscalzo J; Hall JL
    Circulation; 2016 Jan; 133(2):226-31. PubMed ID: 27028435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative cancer genomics in the era of precision cancer medicine.
    Inazawa J; Miki Y; Nakamura Y
    J Hum Genet; 2021 Sep; 66(9):843. PubMed ID: 34429508
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.
    Levit LA; Kim ES; McAneny BL; Nadauld LD; Levit K; Schenkel C; Schilsky RL
    J Oncol Pract; 2019 Jun; 15(6):325-329. PubMed ID: 30802151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From personalized to precision cancer medicine.
    Baltagiannis EG; Kyrochristos ID; Ziogas DE; Goussia A; Mitsis M; Roukos DH
    Per Med; 2020 Jul; 17(4):245-250. PubMed ID: 32589113
    [No Abstract]   [Full Text] [Related]  

  • 12. Research Ethics Considerations Regarding the Cancer Moonshot Initiative.
    Hammer MJ
    Oncol Nurs Forum; 2016 Jul; 43(4):428-31. PubMed ID: 27314185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.
    Garrido P; Aldaz A; Vera R; Calleja MA; de Álava E; Martín M; Matías-Guiu X; Palacios J
    Clin Transl Oncol; 2018 Apr; 20(4):443-447. PubMed ID: 28861725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Lessons from the Implementation of Genomic Medicine Programs.
    Williams MS
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():389-411. PubMed ID: 30811224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.
    Garrido P; Aldaz A; Calleja MÁ; De Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
    Farm Hosp; 2017 Nov; 41(6):688-691. PubMed ID: 29112494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular pathology - the key to precision oncology].
    Edsjö A; Palmqvist R; Haglund F; Helenius G; Lindqvist O; Fagman H; Botling J
    Lakartidningen; 2021 May; 118():. PubMed ID: 33973224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Precision in "Precision Medicine".
    Chabner BA
    Oncologist; 2016 Sep; 21(9):1029-30. PubMed ID: 27566249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional precision cancer medicine-moving beyond pure genomics.
    Letai A
    Nat Med; 2017 Sep; 23(9):1028-1035. PubMed ID: 28886003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.